Identifying immunohistochemical biomarkers panel for non-small cell lung cancer in optimizing treatment and forecasting efficacy

Identifying immunohistochemical biomarkers panel for non-small cell lung cancer in optimizing treatment and forecasting efficacy

Abstract Background Chemotherapy and immunotherapy for non-small-cell lung cancer (NSCLC) are gaining momentum. However, its long-term efficacy remains limited to only a small fraction of patients. Hence, it is crucial to identify reliable immunohistochemical biomarkers to facilitate the formulation...

Full description

Bibliographic Details
Main Authors: Xiaoya Zhang, Junhong Meng, Mingyue Gao, Cheng Gong, Cong Peng, Duxian Liu
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Cancer
Subjects:
NSCLC
Immunohistochemical biomarkers
Therapeutic decision-making
Prognostic prediction
Machine learning
Online Access:https://doi.org/10.1186/s12885-024-13184-8

Internet

https://doi.org/10.1186/s12885-024-13184-8

Similar Items